These Top CBD Stocks Could be Major Beneficiaries of Cannabis 2.0

Financialnewsmedia.com News Commentary

PALM BEACH, Florida, Oct. 17, 2019 /PRNewswire/ -- The big day for Cannabis 2.0 is here. Today is the day Canada is set to legalize edibles, beverages, and topicals, creating sizable opportunity for growth. Interesting to note, according to analysts at Deloitte, up to 60% of Canadians would use such cannabis edible products. Aurora Cannabis has been so enthralled with the opportunity it expanded into edibles, vapes, and concentrates to take advantage. Canopy Growth Corp. is launching edibles, beverages, and vape products on Cannabis 2.0. Even HEXO Corporation may benefit from its cannabis-infused drinks with Molson Coors Brewing. The big day is opening a wide range of opportunity for companies including The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), Aphria Inc. (NYSE:APHA)(TSX:APHA), Charlotte's Web Holdings Inc. (CSE:CWEB) (OTCQX:CWBHF), Aurora Cannabis Inc. (NYSE:ACB)(TSX:ACB), and CannTrust Holdings Inc. (NASDAQ:CTST).

The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) BREAKING NEWS: The Yield Growth Corp. just announced it has signed a non-binding letter of intent to enter into a co-packing agreement with Apothecary Botanicals, a Canadian licensed cannabis producer and subsidiary of Geyser Brands Inc. (TSX-V: GYSR), for the production and launch of Yield Growth's Canadian Cannabis brand Jack n Jane, a line of cannabis-infused products including tinctures, topicals and capsules. This announcement coincides with Health Canada's official legalization of the production and sale of cannabis extracts and cannabis topicals effective today, marking the one-year anniversary of the legalization of recreational marijuana in Canada. Yield Growth will engage Apothecary Botanicals to manufacture and distribute its Jack n Jane products in British Columbia, combining Yield Growth's proprietary formulations with Apothecary Botanicals' cannabis supply, services, facilities, equipment and required Health Canada licenses for processing and sales. Yield Growth will supply all non-cannabis ingredients, packaging, and design while Apothecary Botanicals will supply cannabis containing THC and/or CBD as required for the various product formulations. The first phase of production is expected to include three tinctures containing THC and CBD, with a goal of coming to market by December 31, 2019.